Cambridge Academic Statement Example: Biology to health policy (Score 93)

My undergraduate training in population health biology has given me an unusual vantage point: I can read epidemiological data as a biologist and ask why the policy response so rarely matches the biological evidence. That tension is what drew me toward health policy, and it is the question I want to pursue rigorously at Cambridge. The clearest moment of intellectual reorientation came during an independent research project in early 2025, in which I synthesised evidence on how biological risk-factor data are translated—or mistranslated—into national health programme design. Working under faculty supervision, I conducted a structured literature review, applied comparative evidence analysis across three country contexts, and produced a recommendation note aimed at a non-specialist policy audience. The exercise exposed a consistent gap: biological findings were routinely stripped of their distributional complexity before reaching decision-makers, producing recommendations that were technically defensible but contextually thin. That finding became the organising question of a working paper currently under departmental review, and it is the question I bring to the MPhil. To test whether the gap was an artefact of academic literature or a live operational problem, I joined a health policy advisory team as a student analyst in summer 2025. My principal task was preparing comparative briefings on implementation risks for a population health intervention, weighing stakeholder priorities against the underlying evidence base. A briefing note I produced was used in an internal planning discussion—a small outcome, but one that confirmed that the translation problem is structural, not incidental. A concurrent internship placement gave me a parallel vantage point: converting a health policy applied project into a concrete output required me to negotiate between epidemiological precision and administrative feasibility, a negotiation I found I could not resolve without a stronger grounding in health systems governance and economic evaluation. The MPhil in Health Policy at Cambridge addresses precisely that gap. The programme's integration of health systems analysis, global health governance, and quantitative policy evaluation maps directly onto the methodological deficits I identified in my own work. I am particularly drawn to the health economics and priority-setting strand, where the question of how biological evidence is weighted against cost and equity considerations is treated as an analytical problem rather than a political given. The opportunity to work within a department that publishes at the intersection of systems thinking and evidence-based policy would allow me to develop the evaluative framework my research has so far lacked. My trajectory is not a departure from biology but a disciplined extension of it. Population health biology asks what makes populations sick; health policy asks what societies choose to do about it. The MPhil is the analytical bridge I need to make that question answerable.